P-ISSN 2587-2400 | E-ISSN 2587-196X

Ahead of Print

Abstracts of Oncology and immunotherapy association 2019 Congress
Abstracts of Oncology and immunotherapy association 2019 Congress
doi: 10.14744/ejmo.2019.2019

MiR-19a Mediates Epithelial Mesenchymal Transition of Breast Cancer by Inhibiting KRAS
Xianchou Xu, Peinan Wen, Yinghao Wang, Adheesh Bhandari, Riyuan Zhang, Shuqiang Shi, Ouchen Wang
doi: 10.14744/ejmo.2021.16863

Follicular Thyroid Adenoma with Signet Ring Cell Morphology; A Rare Case Report
Mehmet Onur Ozturk, Mehmet Celik, Buket Yilmaz Bulbul, Tulin Deniz Yalta, Nuray Can, Semra Ayturk, Sibel Guldiken
doi: 10.14744/ejmo.2017.30602

A case of thyrotoxic hypochalemic periodic paralysis
Yilmaz Inanc, Deniz Tuncel, Mustafa Gokce, Hamza Sahin, Songül Bavli, Yusuf Inanc
doi: 10.14744/ejmo.2017.44154

Dysplastic Adenoma in the Choledochal Cyst of an Adult: Biliary Papillomatosis
Ramazan Saygin Kerimoglu, Ebru Esen, Emet Ebru Nazik, Umut Ulusoy, Sumeyye Kozacioglu, Osman Dogru
doi: 10.14744/ejmo.2017.86580

Abstracts of Oncology and immunotherapy association 2018 Congress
Abstracts Oncology and immunotherapy association
doi: 10.14744/ejmo.2018.2018

ROS1 Rearrangement in Non Small Cell Lung Cancer: Where We are and Where We are going to.
Olga Nigro, Alessandro Tuzi, Graziella Pinotti
doi: 10.14744/ejmo.2020.42771

WEB OF SCIENCE click

  • Impact Factor: 2.5

  • Medicine, General & Internal: Q2 146/322


  • SCOPUS click

  • CiteScoreTracker 2023: 3.6
  • CiteScore year 2022:
    0.9
  • CiteScore year 2021:
    0.2


  • Google Scholar click

  • Number of Articles:315
  • Citations:2587
  • h-index:16
  • i10-index:=26

  • EJMO NLM ID: 101720527

  • Accept Ratio :18.2 %
  • Final decision avg 34 day
  • EJMO & EJMO